FIS vs ZYME · P/E 7.9, rev $2.60B vs rev $76.3M
Fidelity National Information Services Inc (FIS) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Fidelity National Information Services Inc (FIS) is a information technology services company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported FIS revenue for 2024-12-31 was $2.60B. Net income was $282.0M. Revenue was up 1.1% from 2024-09-30 to 2024-12-31. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
FIS currently screens at market cap $21.12B and trailing P/E 7.9. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the FIS and ZYME stock pages for the full models.
Not investment advice.